B

Baroness Merron (Lab)

Speaking in the House of Lords on 18 June 2026

Debate

Prostate Cancer Screening: AI

Contribution

Perhaps I can clarify that the TRANSFORM trial is not exclusive to a particular group. We are looking at people who have susceptibility to prostate cancer because they carry the gene and there is family history. I simply point that out because I hope it will be a reassurance to the noble Lord.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites